Drug intelligence / Profile preview

Goat milk

Development stage: Preclinical
Modality: Small Molecules
Administration: Oral

Overview

Goat milk is a natural product being investigated in a clinical trial for its potential to improve vascular stiffness in patients with mild to moderate hypertension. It is administered orally at a dose of 2g twice daily.

Targets

DPP-4 (Dipeptidyl Peptidase-IV)

Beyond the preview

Go deeper on Goat milk.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Goat milk.

Explore the full profile